-
VOLUNTARY ANNOUNCEMENT - INCLUSION OF“TENOFOVIR AMIBUFENAMIDE TABLET”IN THE NATIONAL REIMBUREMENT DRUG LIST2021-12-03
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 20212021-12-01
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF“FULVESTRANT INJECTION”2021-11-19
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME2021-11-05
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 20212021-11-03
-
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH SILENCE THERAPEUTICS2021-10-15
-
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH OLIX PHARMACEUTICALS2021-10-12
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF“HS-10381 CAPSULES”2021-10-11
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 20212021-10-07
-
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF“PEG SIHEMATIDE INJECTIONS”ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2021-10-04
-
ANNOUNCEMENT IN RELATION TO RESIGNATION OF NON-EXECUTIVE DIRECTOR2021-09-06
-
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2021-09-06